ALFA Filings
Every announcement, straight from the exchange
Every Shilpa Medicare capacity expansion announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements
Shilpa Biologicals commissioned a cutting‑edge ADC GMP manufacturing facility. The plant expands Shilpa Medicare’s CDMO capabilities for oncology drug substances.
Shilpa Medicare is seeking shareholder approval to shift its registered office from Karnataka to Mumbai, Maharashtra. The move aims to improve access to financial institutions and investors.